(Q36538190)

English

Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis

scientific article published on 19 December 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 August 2017

Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis (English)

1 reference

Europe PubMed Central

14 August 2017

0 references

author name string

M S Freedman

1

1 reference

Europe PubMed Central

14 August 2017

C Metzig

2

1 reference

Europe PubMed Central

14 August 2017

L Kappos

3

1 reference

Europe PubMed Central

14 August 2017

C H Polman

4

1 reference

Europe PubMed Central

14 August 2017

G Edan

5

1 reference

Europe PubMed Central

14 August 2017

H-P Hartung

6

1 reference

Europe PubMed Central

14 August 2017

D H Miller

7

1 reference

Europe PubMed Central

14 August 2017

X Montalban

8

1 reference

Europe PubMed Central

14 August 2017

J Yarden

9

1 reference

Europe PubMed Central

14 August 2017

L Spector

10

1 reference

Europe PubMed Central

14 August 2017

E Fire

11

1 reference

Europe PubMed Central

14 August 2017

N Dotan

12

1 reference

Europe PubMed Central

14 August 2017

S Schwenke

13

1 reference

Europe PubMed Central

14 August 2017

V Lanius

14

1 reference

Europe PubMed Central

14 August 2017

R Sandbrink

15

1 reference

Europe PubMed Central

14 August 2017

C Pohl

16

1 reference

Europe PubMed Central

14 August 2017

publication date

19 December 2011

1 reference

Europe PubMed Central

14 August 2017

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

14 August 2017

18

1 reference

Europe PubMed Central

14 August 2017

7

1 reference

Europe PubMed Central

14 August 2017

966-973

1 reference

Europe PubMed Central

14 August 2017

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

Clinical prognostic factors in multiple sclerosis: a natural history review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

Anti-alpha-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

Induction vs. escalation of therapy for relapsing multiple sclerosis: the evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

The incomplete nature of multiple sclerosis relapse resolution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

Baseline MRI predicts future attacks and disability in clinically isolated syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

The importance of early diagnosis of multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

Effect of relapses on development of residual deficit in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

A new kind of carbohydrate array, its use for profiling antiglycan antibodies, and the discovery of a novel human cellulose-binding antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

Immunological indicators of disease activity and prognosis in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

30 September 2017

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

28 June 2018

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

28 June 2018

Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

21 September 2018

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

21 September 2018

Antimyelin antibodies with no progression to multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

21 September 2018

Lack of association between antimyelin antibodies and progression to multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

21 September 2018

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

21 September 2018

Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

21 September 2018

The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

21 September 2018

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3546632

21 September 2018

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511432327

21 January 2018

Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511432327

21 January 2018

Multiple sclerosis-from probable to definite diagnosis: a 7-year prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22183938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course

1 reference

https://pubmed.ncbi.nlm.nih.gov/22183938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22183938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relapses and progression of disability in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22183938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1177/1352458511432327

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36538190&oldid=1637359889"